MediWound Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MDWD Nasdaq 2836 www.mediwound.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MediWound Ltd.

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference - Jan 12th, 2026 5:00 am
MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% - Dec 19th, 2025 5:54 am
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries - Dec 10th, 2025 5:00 am
MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth Plans - Nov 22nd, 2025 5:20 am
MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ... - Nov 20th, 2025 2:00 pm
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates - Nov 20th, 2025 6:10 am
MediWound: Q3 Earnings Snapshot - Nov 20th, 2025 5:10 am
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 20th, 2025 5:00 am
RenovoRx, Inc. (RNXT) Reports Q3 Loss, Lags Revenue Estimates - Nov 13th, 2025 3:30 pm
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 3:15 pm
FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates - Nov 10th, 2025 4:00 pm
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates - Nov 6th, 2025 3:55 pm
MediWound to Report Third Quarter 2025 Financial Results - Nov 5th, 2025 5:30 am
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® - Nov 3rd, 2025 6:00 am
MediWound announces $30M registered direct offering - Sep 30th, 2025 6:45 am
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares - Sep 29th, 2025 6:37 am
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia - Sep 25th, 2025 5:30 am
MediWound's (NASDAQ:MDWD) investors will be pleased with their notable 84% return over the last three years - Sep 23rd, 2025 6:11 am
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress - Sep 2nd, 2025 5:30 am
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Aug 20th, 2025 5:30 am